Endothelin converting enzyme 1: Difference between revisions

Revision as of 14:24, 20 March 2019

Revision as of 19:32, 20 March 2019

Line 11:

==Further reading==

{{refbegin | 2}}

{{PBB_Further_reading

| citations =

*{{cite journal | vauthors=Yorimitsu K, Moroi K, Inagaki N |title=Cloning and sequencing of a human endothelin converting enzyme in renal adenocarcinoma (ACHN) cells producing endothelin-2 |journal=Biochem. Biophys. Res. Commun. |volume=208 |issue= 2 |pages= 721–7 |year= 1995 |pmid= 7695628 |doi=10.1006/bbrc.1995.1397 |display-authors=etal}}

*{{cite journal | vauthors=Schmidt M, Kröger B, Jacob E |title=Molecular characterization of human and bovine endothelin converting enzyme (ECE-1) |journal=FEBS Lett. |volume=356 |issue= 2–3 |pages= 238–43 |year= 1995 |pmid= 7805846 |doi=10.1016/0014-5793(94)01277-6 |display-authors=etal}}

Line 34 ⟶ 32:

*{{cite journal | vauthors=Masatsugu K, Itoh H, Chun TH |title=Shear stress attenuates endothelin and endothelin-converting enzyme expression through oxidative stress |journal=Regul. Pept. |volume=111 |issue= 1–3 |pages= 13–9 |year= 2003 |pmid= 12609744 |doi=10.1016/S0167-0115(02)00219-7 |display-authors=etal}}

*{{cite journal | vauthors=Smollich M, Götte M, Yip GW |title=On the role of endothelin-converting enzyme 1 (ECE-1) and neprilysin in human breast cancer |journal=Breast Cancer Res. Treat. |volume=106 |issue= 3 |pages= 361–9 |year= 2007 |pmid= 17295044 |doi= 10.1007/s10549-007-9516-9 |display-authors=etal}}

}}

{{refend}}